187 abbreviations from the guideline and its supplement.
- ACE-(I)
- Angiotensin-converting enzyme(-inhibitor)
- ACHD
- Adult congenital heart disease
- ACS
- Acute coronary syndrome
- ADR
- Adverse drug reaction
- AF
- Atrial fibrillation
- AFL
- Atrial flutter
- AHF
- Acute heart failure
- AHT
- Arterial hypertension
- ALARA
- As low as reasonably achievable
- ALT
- Alanine transaminase
- AMVP
- Arrhythmic mitral valve prolapse
- APO
- Adverse pregnancy outcomes
- aPTT
- Activated partial thromboplastin time
- ARB
- Angiotensin receptor blocker
- ARNI
- Angiotensin receptor/neprilysin inhibitor
- ARVC
- Arrhythmogenic right ventricular cardiomyopathy
- AS
- Aortic stenosis
- ASA
- Acetylsalicylic acid
- ASCVD
- Atherosclerotic cardiovascular disease
- ASD
- Atrial septal defect
- ASI
- Aortic size index
- AST
- Aspartate aminotransferase
- AT
- Atrial tachycardia
- AUC
- Area under the curve
- AV
- Atrioventricular
- AV(N)RT
- Atrioventricular (nodal) re-entry tachycardia
- AVSD
- Atrioventricular septal defect
- B-blocker
- Beta-blocker
- b.i.d.
- Bis in die (twice a day)
- b.p.m.
- Beats per minute
- BAV
- Bicuspid aortic valve
- BMI
- Body mass index
- BNP
- Brain natriuretic peptide
- BP
- Blood pressure
- BrS
- Brugada syndrome
- C
- Maximum concentration
- CABG
- Coronary artery bypass graft
- CAD
- Coronary artery disease
- CARPREG II
- Cardiac Disease in Pregnancy study II
- CCB
- Calcium channel blocker
- CCS
- Chronic coronary syndromes
- CI
- Confidence interval
- CMP
- Cardiomyopathy
- CMR
- Cardiovascular magnetic resonance
- CNS
- Central nervous system
- CO
- Cardiac output
- COR
- Class of recommendation
- CPG
- Clinical Practice Guidelines
- CPR
- Cardiopulmonary resuscitation
- CPVT
- Catecholaminergic polymorphic ventricular tachycardia
- CT
- Computed tomography
- cTnI
- Cardiac troponin I
- cTnT
- Cardiac troponin T
- CTPA
- Computed tomography pulmonary angiography
- CTRCD
- Cancer-therapy-related cardiac dysfunction
- CVD
- Cardiovascular disease
- DAPT
- Dual antiplatelet therapy
- DBP
- Diastolic blood pressure
- DCM
- Dilated cardiomyopathy
- DOAC
- Direct oral anticoagulant
- DVT
- Deep vein thrombosis
- ECG
- Electrocardiogram
- ECMO
- Extracorporeal membrane oxygenation
- EF
- Ejection fraction
- EORP
- EURObservational Research Programme
- ERA
- Endothelin receptor antagonist
- ESC
- European Society of Cardiology
- ESH
- European Society of Hypertension
- FAT
- Focal atrial tachycardia
- FDA
- Food and Drug Administration
- FFP
- Fresh frozen plasma
- GD
- Gestation day
- GDM
- Gestational diabetes mellitus
- GnRH
- Gonadotropin-releasing hormone
- HCM
- Hypertrophic cardiomyopathy
- HELLP
- Haemolysis, elevated liver enzymes, low platelet count
- HF
- Heart failure
- HFrEF
- Heart failure with reduced ejection fraction
- HIV
- Human immunodeficiency virus
- HLA
- Human leucocyte antigen
- HR
- Heart rate
- HTAD
- Heritable thoracic aortic disease
- i.v.
- Intravenous
- ICD
- Implantable cardioverter defibrillator
- INR
- International normalized ratio
- IP
- Prostaglandin I2
- IRR
- Incidence rate ratio
- IU
- International unit
- IUD
- Intrauterine device
- IUGR
- Intrauterine growth restriction
- IVF
- In vitro
- KLH
- Keyhole limpet haemocyanin
- LA
- Left artery
- LDL
- Low-density lipoprotein
- LDS
- Loeys–Dietz syndrome
- LMWH
- Low-molecular-weight heparin
- LQT1/2/3
- Long QT syndrome type 1, 2, or 3
- LQT2
- Long QT syndrome type 2
- LQTS
- Long QT syndrome
- LV
- Left ventricle
- LVAD
- Left ventricular assist device
- LVEDD
- Left ventricular end-diastolic diameter
- LVEF
- Left ventricular ejection fraction
- LVH
- Left ventricular hypertrophy
- LVOT(O)
- Left ventricular outflow tract (obstruction)
- LVOTO
- Left ventricular outflow tract obstruction
- MACE
- Major adverse cardiovascular events
- MFS
- Marfan syndrome
- MHV
- Mechanical heart valve
- MINOCA
- Myocardial infarction with non-obstructive coronary arteries
- MR
- Mitral valve regurgitation
- MRA
- Mineralocorticoid receptor antagonist
- MRHD
- Maximum recommended human dose
- MS
- Mitral stenosis
- mTOR
- Mammalian target of rapamycin
- mU
- Milliunit
- mWHO
- modified World Health Organization
- NA
- Not applicable
- NDLVC
- Non-dilated left ventricular cardiomyopathy
- NP
- Natriuretic peptide
- NSAID
- Non-steroidal anti-inflammatory drug
- nsHTAD
- Non-syndromic heritable thoracic aortic disease
- NSTE ACS
- Non-ST-elevation myocardial infarction
- NT-proBNP
- N-terminal pro-brain natriuretic peptide
- NYHA
- New York Heart Association
- o.d.
- Omni die (once a day)
- oGTT
- Oral glucose tolerance test
- OR
- Odds ratio
- p.o.
- Per os (by mouth)
- P/LP
- Pathogenic/likely pathogenic
- PAH
- Pulmonary arterial hypertension
- PAP
- Pulmonary arterial pressure
- PASP
- Pulmonary arterial systolic pressure
- PCI
- Percutaneous coronary intervention
- PE
- Pulmonary embolism
- PgP
- P-glycoprotein
- PH
- Pulmonary hypertension
- PlGF
- Placental growth factor
- PPCM
- Peripartum cardiomyopathy
- PPH
- Post-partum haemorrhage
- PREM
- Patient-reported experience measure
- PROM
- Patient-reported outcome measure
- PV
- Pulmonary valve
- QRS
- Q, R, and S waves
- QTc
- Corrected QT interval
- RAAS
- Renin angiotensin aldosterone system
- RBC
- Red blood cell
- RHD
- Recommended human dose
- RID
- Relative infant dose
- ROPAC
- Registry of Pregnancy and Cardiac Disease
- ROSC
- Return of spontaneous circulation
- RV
- Right ventricle
- RVEF
- Right ventricular ejection fraction
- RVH
- Right ventricular hypertrophy
- RVOT-VT
- Right ventricular outflow tract ventricular tachycardia
- RVOT(O)
- Right ventricular outflow tract (obstruction)
- SBP
- Systolic blood pressure
- SCAD
- Spontaneous coronary artery dissection
- SGA
- Small for gestational age
- SGLT2
- Sodium–glucose co-transporter-2
- SPAP
- Systolic pulmonary artery pressure
- SpO
- Oxygen saturation
- SQTS
- Short QT syndrome
- SSRI
- Selective serotonin reuptake inhibitors
- STEMI
- ST-elevation myocardial infarction
- SVT
- Supraventricular tachycardia
- T
- Time to maximum concentration
- TAD
- Thoracic aortic disease
- TAVI
- Transcatheter aortic valve implantation
- TGA
- Transposition of the great arteries
- TOF
- Tetralogy of Fallot
- TPVI
- Transcatheter pulmonary valve implementation
- TR
- Tricuspid regurgitation
- TS
- Turner syndrome
- TTE
- Transthoracic echocardiogram
- UACR
- Urine albumin–creatinine ratio
- UFH
- Unfractionated heparin
- VA-ECMO
- Veno-arterial extracorporeal membrane oxygenation
- VF
- Ventricular fibrillation
- VHD
- Valvular heart disease
- VKA
- Vitamin K antagonist
- VSD
- Ventricle septal defect
- VT
- Ventricular tachycardia
- VTE
- Venous thromboembolism
- WCD
- Wearable cardioverter defibrillator
- WHO
- World Health Organization
- WPW
- Wolff–Parkinson–White